Irish Biotech Aerska raises $21 million to advance RNA therapies for brain diseases
DUBLIN: Irish biotechnology start-up Aerska has secured $21 million (€18 million) in seed funding to accelerate the development of RNA-based therapies targeting degenerative neurological diseases such as Alzheimer’s and Parkinson’s. The funding round was co-led by venture firms Backed VC and Age1, with additional support from Blueyard, Lingotto, Kerna Ventures, Norrsken, and Speedinvest. The investment…